Date Filed | Type | Description |
08/22/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.
Txns:
| Granted 9,196 restricted stock units
@ $0 |
|
07/27/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.
Txns:
| Exercised 14,060 restricted stock units
@ $0 |
|
06/01/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.
Txns:
| Exercised 1,752 restricted stock units
@ $0 |
|
05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc
Txns:
| Granted 1,930 shares
@ $90.68, valued at
$175k
Paid exercise price by delivering 169 shares
@ $90.23, valued at
$15.2k
|
|
05/01/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Exercised 670 restricted stock units
@ $0 |
|
03/02/2023 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.
Txns:
| Granted 7,006 restricted stock units
@ $0 |
|
07/27/2022 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Accolade, Inc.
Txns:
| Granted 14,060 restricted stock units
@ $0 |
|
07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns:
| Granted 65,000 options to buy
@ $5.31, valued at
$345.2k
|
|
05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2020 |
4/A
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Sold 30,000 shares
@ $66, valued at
$2M
|
|
05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/30/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc
Txns:
| Paid exercise price by delivering 393 shares
@ $99.14, valued at
$39k
|
|
04/30/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Granted 18,270 options to buy
@ $46.37, valued at
$847.2k
|
|
04/29/2020 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc
Txns:
| Granted 1,737 shares
@ $0 |
|
06/28/2019 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Granted 54,660 options to buy
@ $14.34, valued at
$783.8k
|
|
06/12/2019 |
4/A
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc
Txns:
| Granted 2,002 shares
@ $0 Paid exercise price by delivering 429 shares
@ $88.81, valued at
$38.1k
|
|
05/01/2019 |
4
| NABEL ELIZABETH G (Director) has filed a Form 4 on Medtronic plc
Txns:
| Granted 2,002 shares
@ $0 Paid exercise price by delivering 429 shares
@ $88.81, valued at
$38.1k
|
|
12/19/2018 |
3
| NABEL ELIZABETH G (Director) has filed a Form 3 on Tekla World Healthcare Fund |
12/19/2018 |
3
| NABEL ELIZABETH G (Director) has filed a Form 3 on Tekla Healthcare Opportunities Fund |
12/19/2018 |
3
| NABEL ELIZABETH G (Director) has filed a Form 3 on TEKLA LIFE SCIENCES INVESTORS |
12/19/2018 |
3
| NABEL ELIZABETH G (Director) has filed a Form 3 on TEKLA HEALTHCARE INVESTORS |
|